This Article Full Text Full Text (PDF) Supplementary Data All Versions of this Article: 0008-5472.CAN-08-4155v1 69/11/4926    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Google Scholar Articles by Viloria, C. G. Articles by López-Otín, C. PubMed PubMed Citation Articles by Viloria, C. G. Articles by López-Otín, C.

Genetic Inactivation of ADAMTS15 Metalloprotease in Human Colorectal Cancer

¹ Departamento de Bioquímica y Biología Molecular and ² Biología Funcional, Facultad de Medicina, Instituto Universitario de Oncología, Universidad de Oviedo, ³ Servicio de Anatomía Patológica, Hospital Central de Asturias, Oviedo, Spain and ⁴ Laboratori de Recerca Translacional, IDIBELL, Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain

Requests for reprints: Carlos López-Otín, Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Instituto Universitario de Oncología, Universidad de Oviedo, 33006 Oviedo, Spain. Phone: 34-985-104201; Fax: 34-985-103564; E-mail: clo{at}uniovi.es.

Key Words: protease • thrombospondin • mutations • tumor suppressor gene • colon carcinoma

Matrix metalloproteinases have been traditionally linked to cancer dissemination through their ability to degrade most extracellular matrix components, thus facilitating invasion and metastasis of tumor cells. However, recent functional studies have revealed that some metalloproteases, including several members of the ADAMTS family, also exhibit tumor suppressor properties. In particular, ADAMTS1, ADAMTS9, and ADAMTS18 have been found to be epigenetically silenced in malignant tumors of different sources, suggesting that they may function as tumor suppressor genes. Herein, we show that ADAMTS15 is genetically inactivated in colon cancer. We have performed a mutational analysis of the ADAMTS15 gene in human colorectal carcinomas, with the finding of four mutations in 50 primary tumors and 6 colorectal cancer cell lines. Moreover, functional in vitro and in vivo studies using HCT-116 and SW-620 colorectal cancer cells and severe combined immunodeficient mice have revealed that ADAMTS15 restrains tumor growth and invasion. Furthermore, the presence of ADAMTS15 in human colorectal cancer samples showed a negative correlation with the histopathologic differentiation grade of the corresponding tumors. Collectively, these results provide evidence that extracellular proteases, including ADAMTS15, may be targets of inactivating mutations in human cancer and further validate the concept that secreted metalloproteases may show tumor suppressor properties. [Cancer Res 2009;69(11):4926–34]

This article has been cited by other articles:

				S. S. Apte A Disintegrin-like and Metalloprotease (Reprolysin-type) with Thrombospondin Type 1 Motif (ADAMTS) Superfamily: Functions and Mechanisms J. Biol. Chem., November 13, 2009; 284(46): 31493 - 31497. [Abstract] [Full Text] [PDF]